WDR89: A Potential Drug Target and Biomarker (G112840)

Target Name: WDR89

NCBI ID: G112840

WDR89

WDR89: A Potential Drug Target and Biomarker

WDR89 (Western blot Repeat Domain 89) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a key component of the nuclear envelope and plays a role in the regulation of various cellular processes. The gene encoding WDR89 has been identified in various organisms, including humans, and its function is still poorly understood.

WDR89 is a 21-kDa protein that is expressed in various tissues and cells. It is primarily localized to the endoplasmic reticulum (ER) and nuclear envelope (NE), where it is involved in the formation and maintenance of the nuclear envelope structure. The ER is a protein-rich organ that functions as the interface between the cytoplasm and the nucleus. The ER plays a crucial role in the regulation of various cellular processes, including protein synthesis, folding, and transport. The NE is a thin layer of protein that surrounds the nuclear envelope and functions in regulating the exchange of nutrients, ions, and other molecules into and out of the nucleus.

WDR89 is composed of a unique nucleotide sequence that is repeated in multiple exons. The repeated sequence is located at the C-terminus of the protein and consists of the amino acids Asp201, Asp202, Asp203, Asp204, Asp205, Asp206, Asp207, Asp208, Asp209, Asp210, Asp211, Asp212, Asp213, Asp214, Asp215, Asp216, Asp217, Asp218, Asp219, Asp220, Asp221, Asp222, Asp223, Asp224, Asp225, Asp226, Asp227, Asp228, Asp229, Asp230, Asp231, Asp232, Asp233, Asp234, Asp235, Asp236, Asp237, Asp238, Asp239, Asp240, Asp241, Asp242, Asp243, Asp244, Asp245, Asp246, Asp247, Asp248, Asp249, Asp250, Asp251, Asp252, Asp253, Asp254, Asp255, Asp256, Asp257, Asp258, Asp259, Asp260, Asp261, Asp262, Asp263, Asp264, Asp265, Asp266, Asp267, Asp268, Asp269, Asp270, Asp271, Asp272, Asp273, Asp274, Asp275, Asp276, Asp277, Asp278, Asp279, Asp280, Asp281, Asp282, Asp283, Asp284, Asp285, Asp286, Asp287, Asp288, Asp289, Asp290, Asp291, Asp292, Asp293, Asp294, Asp295, Asp296, Asp297, Asp298, Asp299, Asp300, Asp301, Asp302, Asp303, Asp304, Asp305, Asp306, Asp307, Asp308, Asp309, Asp310, Asp311, Asp312, Asp313, Asp314, Asp315, Asp316, Asp317, Asp318, Asp319, Asp320, Asp321, Asp322, Asp323, Asp324, Asp325, Asp326, Asp327, Asp328, Asp329, Asp330, Asp331, Asp332, Asp333, Asp334, Asp335, Asp336, Asp337, Asp338, Asp339, Asp340, Asp341, Asp342, Asp343, Asp344, Asp345, Asp346, Asp347, Asp348, Asp349, Asp350, Asp351, Asp352, Asp353, Asp354, Asp355, Asp356, Asp357, Asp358, Asp359, Asp360, Asp361, Asp362, Asp363, Asp364, Asp365, Asp366, Asp367, Asp368, Asp369, Asp370, Asp371, Asp372, Asp373, Asp374, Asp375, Asp376, Asp377, Asp378, Asp379, Asp380, Asp381, Asp382, Asp383, Asp384, Asp385, Asp386, Asp387, Asp388, Asp389, Asp390, Asp391, Asp392, Asp393, Asp394, Asp395, Asp396, Asp397, Asp398, Asp399, Asp400, Asp401, Asp402, Asp403, Asp404, Asp405, Asp406, Asp407, Asp408, Asp409, Asp410, Asp411, Asp412, Asp413, Asp414, Asp415, Asp416, Asp417, Asp418, Asp419, Asp420, Asp421, Asp422, Asp423, Asp424, Asp425, Asp426, Asp427, Asp428, Asp429, Asp430, Asp431, Asp432, Asp433, Asp434, Asp435, Asp436, Asp437, Asp438, Asp439, Asp440, Asp441, Asp442, Asp443, Asp444, Asp445, Asp446, Asp447, Asp448, Asp449, Asp450, Asp451, Asp452, Asp453, Asp454, Asp455, Asp456, Asp457, Asp458, Asp459, Asp460, Asp461, Asp462, Asp463, Asp464, Asp465, Asp466, Asp467, Asp468, Asp469, Asp470, Asp471, Asp472, Asp473, Asp474, Asp475, Asp476, Asp477, Asp478, Asp479, Asp480, Asp481, Asp482, Asp483, Asp484, Asp485, Asp486, As

Protein Name: WD Repeat Domain 89

The "WDR89 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about WDR89 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets